The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
MaaT Pharma Provides Update on MaaT013 (Xervyteg®) Potential Development Plan Following CHMP Negative Opinion After Re-examination• Evvy Raises $40M Series B to Scale AI-Powered Precision Diagnostics & Care Platform for Women’s Health• Armata Pharmaceuticals Receives U.S. FDA Breakthrough Therapy Designation for AP-SA02• GutAlive®: Microbiota Collection and Transport in Anaerobic Conditions• From Discovery to Disease Prevention: How the Biose–Siolta Partnership is Advancing a New Generation of Live Biotherapeutics• A pioneering gut bacterium passes Europe’s food-safety review under the EU Novel Food Regulation•

Microbiome Times

Biomica Reports Positive Preliminary Results in Animal Studies in Its Immuno-oncology Program
Oncology

Biomica Reports Positive Preliminary Results in Animal Studies in Its Immuno-oncology Program

NOV 12, 2019
Deerland Probiotics & Enzymes Announces Acquisition of Bifodan A/S
Biotics and Supplements

Deerland Probiotics & Enzymes Announces Acquisition of Bifodan A/S

NOV 11, 2019
Million Microbiome of Humans Project (MMHP) is launched, aiming to build the world’s largest human microbiome database
Editor's Choice

Million Microbiome of Humans Project (MMHP) is launched, aiming to build the world’s largest human microbiome database

NOV 9, 2019
Enterome Enters Research Collaboration Focused on Microbiome-derived Immunotherapies
Pharma & Human Health

Enterome Enters Research Collaboration Focused on Microbiome-derived Immunotherapies

NOV 7, 2019
OraSure Technologies, Inc. Announces Purchase of Diversigen
Finance

OraSure Technologies, Inc. Announces Purchase of Diversigen

NOV 7, 2019
Even the fetus has gut bacteria, study shows
Pharma & Human Health

Even the fetus has gut bacteria, study shows

NOV 2, 2019
Chardan Healthcare Acquisition Corp. Completes Merger with BiomX Ltd.
Finance

Chardan Healthcare Acquisition Corp. Completes Merger with BiomX Ltd.

NOV 2, 2019
Arranta Bio announces $82M in new funding, and a strategic partnership with Thermo Fisher Scientific
Finance

Arranta Bio announces $82M in new funding, and a strategic partnership with Thermo Fisher Scientific

NOV 2, 2019
Group examines the unique challenges of clinical trials for development of microbiotic medicinal products, including live biotherapeutic products
Clinical & Manufacturing

Group examines the unique challenges of clinical trials for development of microbiotic medicinal products, including live biotherapeutic products

OCT 29, 2019
Half of all commonly used drugs profoundly affecting the gut microbiome, warn experts
Gastrointestinal

Half of all commonly used drugs profoundly affecting the gut microbiome, warn experts

OCT 26, 2019
Standardization in microbiome measurements Considerations from sampling to analysis
Editor's Choice

Standardization in microbiome measurements Considerations from sampling to analysis

OCT 25, 2019